Future medicinal chemistry - JoVE Visualize

Showing results (2371-2380 of 2,373) with videos related to

Pageof 238

Sort By:

You have reached the last page of results.This site can display upto 2,373 results.

Future Medicinal Chemistry|September 11, 2026

Bis-thiosemicarbazone derivative as starting agent for synthesis of anti-breast cancer agents and targeting PIM-1 kinaseAlaa M Abu Alnjaa, Jihan Qurban, Eman M H Abbas, et al.

Future Medicinal Chemistry|September 7, 2026

Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agentsAhmed M Metwaly, Hazem Elkady, Walid E Elgammal, et al.

Future Medicinal Chemistry|September 15, 2026

Exploring the antidiabetic potential of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids: synthesis, α-glucosidase inhibition and molecular modeling studiesAnshul Grover, Vivek Asati, Jayant Sindhu, et al.

Pageof 238

Showing results (2371-2380 of 2,373) with videos related to

Sort By:

Pageof 238

You have reached the last page of results.This site can display upto 2,373 results.

Future Medicinal Chemistry|September 11, 2026

Bis-thiosemicarbazone derivative as starting agent for synthesis of anti-breast cancer agents and targeting PIM-1 kinaseAlaa M Abu Alnjaa, Jihan Qurban, Eman M H Abbas, et al.

Future Medicinal Chemistry|September 7, 2026

Integrated in vitro and in silico evaluations of novel benzanilide derivatives as anticancer agentsAhmed M Metwaly, Hazem Elkady, Walid E Elgammal, et al.

Future Medicinal Chemistry|September 15, 2026

Exploring the antidiabetic potential of DHA-salicylaldehyde-chalcone endowed 1,2,3-triazole hybrids: synthesis, α-glucosidase inhibition and molecular modeling studiesAnshul Grover, Vivek Asati, Jayant Sindhu, et al.

Pageof 238